Michael Berger

11PUBLICATIONS
37CO-AUTHORS
Chemical and thermal processes in energy and combustionPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 09, 2025
Metabolic reprogramming driven by Ant2 deficiency augments T Cell function and anti-tumor immunity in mice.

Omri Yosef, Leonor Cohen-Daniel, Oded Shamriz

|Jul 22, 2024
Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice.

Benjamin Assouline, Rachel Kahn, Lutfi Hodali

|Jan 11, 2024
Renal Mitochondrial ATP Transporter Ablation Ameliorates Obesity-Induced CKD.

Anna Permyakova, Sharleen Hamad, Liad Hinden

|Oct 03, 2022
S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair.

Adi Amar-Schwartz, Vered Ben Hur, Amina Jbara

|Nov 23, 2020
Systemic hypoxia inhibits T cell response by limiting mitobiogenesis via matrix substrate-level phosphorylation arrest.

Amijai Saragovi, Ifat Abramovich, Ibrahim Omar

|Mar 24, 2020
Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.

O Shamriz, A J Simon, A Lev

Pageof 2

Frequent Collaborators

2 joint publications

Joseph Tam

2 joint publications

Omri Yosef

1 joint publications

Yujin Hoshida

1 joint publications

Eran Rosenthal